CDNA Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$70.33median target· current $87.41 (-19.5%)7 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio42.02Forward 256.41
EPS (TTM)$2.081067.0% YoY
Profit margin25.9%HEALTHCARE
Market cap$4.52BMid cap
Valuation
- Forward P/E
- 256.41
- PEG ratio
- -0.12
- P/B
- 9.82
- P/S (TTM)
- 9.09
- EV/EBITDA
- 157.14
Profitability & growth
- ROE (TTM)
- 33.0%
- Operating margin
- 5.8%
- Revenue growth YoY
- 39.3%
- Dividend yield
- —
- Beta
- 2.38
Last earnings
Oct 29, 2026 · Estimate $0.07 · Reported $0.52
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About CareDx Inc
Company profileCareDx, Inc. discovers, develops and markets diagnostic solutions for transplant patients and caregivers globally. The company is headquartered in South San Francisco, California.
Classification
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 8000 MARINA BOULEVARD, BRISBANE, CA
- Fiscal year end
- December
- Latest quarter
- Sep 30, 2026
Market cap$4.52B
Shares outstanding$51.7M
52W high$90.87
52W low$14.27
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent